Compare HOTH & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOTH | TSE |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 19.9M |
| IPO Year | 2019 | 2014 |
| Metric | HOTH | TSE |
|---|---|---|
| Price | $0.95 | $0.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $4.50 | $1.00 |
| AVG Volume (30 Days) | 649.7K | ★ 1.2M |
| Earning Date | 11-12-2025 | 02-13-2026 |
| Dividend Yield | N/A | ★ 4.00% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,133,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.66 | $0.43 |
| 52 Week High | $2.12 | $5.99 |
| Indicator | HOTH | TSE |
|---|---|---|
| Relative Strength Index (RSI) | 34.10 | 38.28 |
| Support Level | $1.00 | $0.43 |
| Resistance Level | $1.13 | $0.95 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 3.67 | 5.02 |
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.